Lifesaving health initiatives and medical research projects have shut down around the world in response to the Trump administration’s 90-day pause on foreign aid and stop-work orders.In Uganda, the National…
New Delhi : CURO Biosciences Private Limited, operating under the name ErlySign, has raised ₹16 crore in pre-Series A funding from investor Ashish Kacholia. The funding, facilitated by DerivativeSaint, a…
New Delhi: Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous system to machines.…
London: The pharmaceutical industry has experienced a notable uptick in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology over the past five years. These…
Sarpagandha (rauvolfia serpentine) medicinal plant. File. | Photo Credit: K. Ravikumar NEW DELHIThe U.K.’s policy towards Ayurveda products is not part of negotiations on the India-UK Free Trade Agreement (FTA),…
Shahid Akhter, editor, ETHealthworld, spoke to Jaideep Bajaj, Chairman, ZS, to figure out how AI applications will accelerate the future of healthcare.AI in healthcareAI can have everything from macro applications…
New Delhi: Artificial Intelligence (AI) can help fight systemic challenges straining global healthcare systems with AI-driven diagnosis, infectious disease intelligence and clinical trial optimisation showing the highest potential, a new…
The medicine you took this morning traveled a long route to get from the lab to your pill pack. First, there's extensive lab research. Then, animal testing. But before a medicine…
by Shuvankar PramanickEvery industry in today’s world has been touched by technological advancements, and healthcare is no different. The healthcare industry has transformed significantly throughout the years, with much of…
May 26, 2022 – Trishna Bharadia has multiple sclerosis and works as a patient engagement consultant and is often asked to take part in clinical trials. Mostly, though, she turns…